MariMed (OTCMKTS:MRMD) Issues Earnings Results

MariMed (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01), Zacks reports. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.

MariMed Stock Down 8.0%

Shares of MRMD stock traded down $0.01 on Wednesday, hitting $0.06. 460,212 shares of the stock were exchanged, compared to its average volume of 508,118. The company has a current ratio of 0.95, a quick ratio of 0.34 and a debt-to-equity ratio of 1.67. The firm has a market capitalization of $25.71 million, a P/E ratio of -2.14 and a beta of 1.33. MariMed has a fifty-two week low of $0.06 and a fifty-two week high of $0.23. The business has a 50-day moving average of $0.07 and a 200 day moving average of $0.08.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.